Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Insulin (NN729 Process) vs Current Process in Type 1 Diabetes
NCT00569400Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2003
- Primary completion
- Jan 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of regular human insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Change of human insulin antibodies at 26 weeks. Started May 2003; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00569400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569400.